Voisard Asset Management Group, Inc. Vertex Pharmaceuticals Inc Transaction History
Voisard Asset Management Group, Inc.
- $205 Billion
- Q2 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 281 shares of VRTX stock, worth $138,131. This represents 0.06% of its overall portfolio holdings.
Number of Shares
281
Previous 296
5.07%
Holding current value
$138,131
Previous $124 Million
6.45%
% of portfolio
0.06%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,637Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.6 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$11.1 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.9 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.49 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $126B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...